240.66BBRL
Type
Common Stock
Exchange
SA
Currency Code
BRL
Currency Name
Brazilian real
Country Name
Brazil
Country ISO
BR
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
19.38
PEG Ratio
1.45
Book Value
19.58
Dividend Share
3.862
Dividend Yield
2.23%
Earnings Share
3.46
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
53,221,998,592
Gross Profit TTM
40,278,999,040
EBITDA
22,086,000,640
Profit Margin
24.16%
Return On Assets TTM
11.42%
Return On Equity TTM
32.89%
Revenue Per Share TTM
26.621
Qtly Revenue Growth YOY
12.40%
Diluted Eps TTM
3.46
Qtly Earnings Growth YOY
38.90%
Trailing PE
19.38
Forward PE
14
Price Sales TTM
24.8825
Price Book MRQ
6.3552
Enterprise Value Revenue
5
Enterprise Value EBITDA
12
55.56
3.44%64.27
2.32%47.30
2.03%304.23
1.41%254.66
1.05%141.40
0.60%56.50
0.44%34.46
-1.91%57.40
-1.58%63.73
-0.56%